A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

[1]  Christopher J. Schofield,et al.  A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage response , 2012, Nature.

[2]  A. Mai,et al.  An analog of BIX-01294 selectively inhibits a family of histone H3 lysine 9 Jumonji demethylases. , 2012, Journal of molecular biology.

[3]  Melanie Leveridge,et al.  Configuration of a High-Content Imaging Platform for Hit Identification and Pharmacological Assessment of JMJD3 Demethylase Enzyme Inhibitors , 2012, Journal of biomolecular screening.

[4]  Akane Kawamura,et al.  Inhibition of 2‐Oxoglutarate Dependent Oxygenases , 2011 .

[5]  B. Gui,et al.  Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14. , 2011, Cancer research.

[6]  C. So,et al.  Transcriptional and epigenetic networks in haematological malignancy , 2011, FEBS letters.

[7]  W. Sippl,et al.  Acyl derivatives of p-aminosulfonamides and dapsone as new inhibitors of the arginine methyltransferase hPRMT1. , 2011, Bioorganic & medicinal chemistry.

[8]  De-Pei Liu,et al.  The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. , 2011, The Journal of clinical investigation.

[9]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[10]  T. Heightman,et al.  Inhibition of the histone demethylase JMJD2E by 3-substituted pyridine 2,4-dicarboxylates. , 2011, Organic & biomolecular chemistry.

[11]  J. Beutler,et al.  Identification of Four Potential Epigenetic Modulators from the NCI Structural Diversity Library Using a Cell-Based Assay , 2010, Journal of biomedicine & biotechnology.

[12]  C. Mao,et al.  Small Molecule Inhibitors as Probes for Estrogen and Androgen Receptor Action* , 2010, The Journal of Biological Chemistry.

[13]  J. Whetstine,et al.  Conserved antagonism between JMJD2A/KDM4A and HP1γ during cell cycle progression. , 2010, Molecular cell.

[14]  Hongtao Yu,et al.  Structural insights into histone lysine demethylation. , 2010, Current opinion in structural biology.

[15]  John D. Minna,et al.  Nuclear Receptor Expression Defines a Set of Prognostic Biomarkers for Lung Cancer , 2010, PLoS medicine.

[16]  A. Jadhav,et al.  Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors , 2010, PloS one.

[17]  R. Janknecht,et al.  Histone demethylase JARID1B/KDM5B is a corepressor of TIEG1/KLF10. , 2010, Biochemical and biophysical research communications.

[18]  J. Ragoussis,et al.  The histone demethylase JMJD2B is regulated by estrogen receptor alpha and hypoxia, and is a key mediator of estrogen induced growth. , 2010, Cancer research.

[19]  M. Mackeen,et al.  Small-molecule-based inhibition of histone demethylation in cells assessed by quantitative mass spectrometry. , 2010, Journal of proteome research.

[20]  Makoto Hasegawa,et al.  Design, synthesis, enzyme-inhibitory activity, and effect on human cancer cells of a novel series of jumonji domain-containing protein 2 histone demethylase inhibitors. , 2010, Journal of medicinal chemistry.

[21]  C. Allis,et al.  Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers , 2010, Nature Reviews Cancer.

[22]  Yang Shi,et al.  Reversal of histone methylation: biochemical and molecular mechanisms of histone demethylases. , 2010, Annual review of biochemistry.

[23]  A. Bookout,et al.  Expression profiling of nuclear receptors in the NCI60 cancer cell panel reveals receptor-drug and receptor-gene interactions. , 2010, Molecular endocrinology.

[24]  Ben S. Wittner,et al.  A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations , 2010, Cell.

[25]  A. Jadhav,et al.  A miniaturized screen for inhibitors of Jumonji histone demethylases. , 2010, Molecular bioSystems.

[26]  Christopher J. Schofield,et al.  Selective Inhibitors of the JMJD2 Histone Demethylases: Combined Nondenaturing Mass Spectrometric Screening and Crystallographic Approaches† , 2010, Journal of medicinal chemistry.

[27]  Yi Zhang,et al.  Histone demethylase JHDM2A is involved in male infertility and obesity. , 2010, Journal of andrology.

[28]  B. Ponder,et al.  Overexpression of the JmjC histone demethylase KDM5B in human carcinogenesis: involvement in the proliferation of cancer cells through the E2F/RB pathway , 2010, Molecular Cancer.

[29]  J. Zimmer,et al.  Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer , 2009, PloS one.

[30]  J. Buggy,et al.  Isoform-specific histone deacetylase inhibitors: the next step? , 2009, Cancer letters.

[31]  Yi Zhang,et al.  Role of Jhdm2a in regulating metabolic gene expression and obesity resistance , 2009, Nature.

[32]  R. Ficner.  Novel structural insights into class I and II histone deacetylases. , 2009, Current topics in medicinal chemistry.

[33]  K. Shimada,et al.  Genome‐wide histone methylation profile for heart failure , 2009, Genes to cells : devoted to molecular & cellular mechanisms.

[34]  P. Tsichlis,et al.  Histone demethylases and cancer. , 2009, Advances in cancer research.

[35]  U. Oppermann,et al.  Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. , 2008, Journal of medicinal chemistry.

[36]  Christopher P Austin,et al.  A quantitative high-throughput screen identifies potential epigenetic modulators of gene expression. , 2008, Analytical biochemistry.

[37]  Patricia A. Ortiz-Tello,et al.  Specificity and mechanism of JMJD2A, a trimethyllysine-specific histone demethylase , 2007, Nature Structural &Molecular Biology.

[38]  James E. Bray,et al.  Crystal structures of histone demethylase JMJD2A reveal basis for substrate specificity , 2007, Nature.

[39]  S. Baylin,et al.  Inhibition of lysine-specific demethylase 1 by polyamine analogues results in reexpression of aberrantly silenced genes , 2007, Proceedings of the National Academy of Sciences.

[40]  P. Trojer,et al.  Target-based approach to inhibitors of histone arginine methyltransferases. , 2007, Journal of medicinal chemistry.

[41]  Paul A Clemons,et al.  The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.

[42]  Juri Rappsilber,et al.  The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3 , 2006, Nature.

[43]  Dirk Eick,et al.  Selective inhibition of c-Myc/Max dimerization and DNA binding by small molecules. , 2006, Chemistry & biology.

[44]  M. Simpson,et al.  Structural Insights into Histone Demethylation by JMJD2 Family Members , 2006, Cell.

[45]  Yang Shi,et al.  Reversal of Histone Lysine Trimethylation by the JMJD2 Family of Histone Demethylases , 2006, Cell.

[46]  Yuan Luo,et al.  A fluoroacetamidine-based inactivator of protein arginine deiminase 4: design, synthesis, and in vitro and in vivo evaluation. , 2006, Journal of the American Chemical Society.

[47]  A. Bookout,et al.  High‐Throughput Real‐Time Quantitative Reverse Transcription PCR , 2005, Current protocols in molecular biology.

[48]  G. Hager,et al.  High-content fluorescence-based screening for epigenetic modulators. , 2006, Methods in enzymology.

[49]  Christopher P Austin,et al.  Fluorescent protein-based cellular assays analyzed by laser-scanning microplate cytometry in 1536-well plate format. , 2006, Methods in enzymology.

[50]  G. Collins.  The next generation. , 2006, Scientific American.

[51]  J. Pollack,et al.  Immortalization of Human Bronchial Epithelial Cells in the Absence of Viral Oncoproteins , 2004, Cancer Research.

[52]  M. Toyoda,et al.  jumonji downregulates cardiac cell proliferation by repressing cyclin D1 expression. , 2003, Developmental cell.

[53]  S. Schreiber,et al.  Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening* , 2001, The Journal of Biological Chemistry.

[54]  T. Langer,et al.  Azinyl and diazinyl hydrazones derived from aryl N-heteroaryl ketones: synthesis and antiproliferative activity. , 1997, Journal of medicinal chemistry.